Atypical Neuroleptic Drug, Olanzapine, in the Treatmentof Impaired Mood
Authors:
M. Bareš
Authors‘ workplace:
Psychiatrické centrum Praha
Published in:
Prakt. Lék. 2000; (6): 329-332
Category:
Overview
In the introduction of their review the authors summarize the pharmacological profile of anatypical neuroleptic preparation olanzapine. The main indication of the drug is treatment ofschizophrenic psychoses. In the contemporary literature with increasing frequency studies areencountered dealing with the use of olanzapine in the treatment of impaired mood (depressivedisorder, bipolar disorder). The authors recapitulate the psychiatric literature on the subjectpublished hitherto. Double blind studies provide preliminary evidence of the effectiveness ofolanzapine in the acute treatment of a depressive disorder and manic episode in the frameworkof a bipolar affective disorder.
Key words:
atypical neuroleptic drug - olanzapine - depressive disorder - bipolar affective
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2000 Issue 6
Most read in this issue
- Effect of Eclipse of the Sun in 1999 on the Psychic State of People
- Cerebrovascular Attacks
- Is the EAV Method Absurd or Unscientific?
- Atypical Neuroleptic Drug, Olanzapine, in the Treatmentof Impaired Mood